Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Rare diseases focused Mereo BioPharma Group said it had appointed Richard Francis as its head of pharmaceutical development.
Francis was previously owner and senior director of Francis Biopharma, where he served as an expert chemistry, manufacturing and controls consultant to over 30 biopharmaceutical clients.
Before founding Francis Biopharma in 2010, he held senior roles at companies including Celltech, Centocor and GlaxoSmithKline.
At 2:25pm: (LON:MPH) Mereo Biopharma Group Ltd share price was -1p at 44.5p